Posts

Biopharma bites: Job cuts at Novartis, fresh funding for MeiraGTx and Fore, plus Boehringer's latest deal – 2026 update

on

Recent Biotech and Pharma News - March 2026

on

Biopharma Bites: Breakout Ventures' $114M AI Fund, Amid Funding Shifts

on

Endpoints News Topics at 2026 JPM Healthcare Conference: CEOs, Investors, China, and Beyond

on

Biopharma’s Winners and Losers of 2025 – Endpoints News recap

on

Recent news on Biopharma Sentiment Index (BPSI)

on

Eli Lilly Signs Up to $2.6 Billion Deal with South Korean Biotech for RNA Medicine Delivery

on

AnaptysBio Halts Phase 2 Ulcerative Colitis Trial; Lyell Immunopharma Secures CAR-T Rights

on

Recent News: Live at 11 a.m. ET – M&A, FDA, MFN and Collaboration with FT

on

No Recent News Specifically About 'Click here to continue reading'

on

Endpoints News Launches Industry Sentiment Survey, But No Evidence Yet of a New Biopharma Sentiment Index

on

LEO Pharma Acquires Exclusive Global Rights for Boehringer Ingelheim’s Psoriasis Drug Spevigo in €90 Million Deal

on

Sernova Chair Resigns After Insider Trading Indictment Tied to Novartis-Chinook Deal

on